These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13663921)

  • 1. [Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative].
    SCARSELLI V
    Farmaco Sci; 1959; 14(5):347-51. PubMed ID: 13663921
    [No Abstract]   [Full Text] [Related]  

  • 2. [On an iodinated derivative of 1,2-diphenyl-4-n-butyl-3,5-pyrazolidinedione].
    CONTI L
    Farmaco Prat; 1961 May; 16():240-3. PubMed ID: 13695183
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of internal diseases with 4-butyl-1, 2-diphenyl-3, 5-pyrazolidinedione and a combination of this drug with 4-dimethylamino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one].
    BEHRE R
    Arzneimittelforschung; 1958 Aug; 8(8):520-5. PubMed ID: 13584244
    [No Abstract]   [Full Text] [Related]  

  • 4. [Toxicity and antiphlogistic effects of 4-(3-chloro-3-buteny1)-1,2-diphenyl-3,5-pyrazolidinedione].
    LENFELD J; KROUTIL M; BOCEK M; CTVRTNIK J; MAYER J
    Arzneimittelforschung; 1961 Apr; 11():427-9. PubMed ID: 13760809
    [No Abstract]   [Full Text] [Related]  

  • 5. [The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione(suxibuzone), antiinflammatory drug. I. Plasma levels and urinary excretion after oral administration of suxibuzone (author's transl)].
    Shindo T; Yasuda Y; Taira K; Mitani N; Kanda A; Akazawa A
    Yakugaku Zasshi; 1979 Dec; 99(12):1186-200. PubMed ID: 120893
    [No Abstract]   [Full Text] [Related]  

  • 6. [The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione (suxibuzone), antiinflammatory drug. II. The biological fate of suxibuzone (SB) after daily oral administration (author's transl)].
    Taira K; Yasuda Y; Shindo T; Mitani N; Akazawa A
    Yakugaku Zasshi; 1980 Mar; 100(3):272-9. PubMed ID: 7381687
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 2: Chemical transformations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (prenazone) and its main decomposition product N,N'-diphenylhydrazide-2-carboxy-5-methyl-4-hexenoic acid in sulphuric acid concentrated.
    Wachowiak R
    Arzneimittelforschung; 1979; 29(5):725-7. PubMed ID: 582968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The osmotic behavior of normal, of inflamed, and of 1,2-diphenyl-4-butyl-3,5-pyrazolidinedione-treated rat liver slices].
    BURCK HC
    Arzneimittelforschung; 1960 Sep; 10():752-5. PubMed ID: 13688929
    [No Abstract]   [Full Text] [Related]  

  • 9. [Some derivatives of 1,2-diphenyl-4-butyl-3, 5-pirazolidine-dione. II].
    FRANCHI G
    Farmaco Sci; 1956; 11(10):819-22. PubMed ID: 13414852
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3,5-pyrazolidinedione. 2. Practical performance of the investigations].
    ECKSTEIN M; LINDNER J; von SCHWEINITZ H
    Arzneimittelforschung; 1960 Nov; 10():902-9. PubMed ID: 13725632
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl pyrazolidine and 3,5-dioxo-1-phenyl-2-p-hydroxyphenyl-4-butyl pyrazolidine on the incorporation of C14-leucine into the blood plasma proteins of the isolated rat liver].
    JUNGBLUT PW
    Arzneimittelforschung; 1959 Sep; 9():549-51. PubMed ID: 14408193
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative studies on the action of 4-butyl-1,2-diphenyl-3, 5-pyrazolidinedione on embryonal fibroblasts, blood and bone marrow cells in vitro].
    ALBRECHT M; ESCHENBACH J; KRETSCHMER V
    Arzneimittelforschung; 1960 Aug; 10():606-12. PubMed ID: 13682160
    [No Abstract]   [Full Text] [Related]  

  • 13. [About the glucoside of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine (phenylbutazone)].
    MOREL CJ
    Experientia; 1958 Aug; 14(8):294-5. PubMed ID: 13574145
    [No Abstract]   [Full Text] [Related]  

  • 14. Facile synthesis of high specific activity 4-[1-
    Singh A; Hakk H; Lupton SJ
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):386-390. PubMed ID: 29274290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the pharmacology of 1-phenyl-2,3-dimethyl-4-isopropylaminopyrazolone (isopyrin) and 1,2-diphenyl-4-butyl-3,5-pyradolidinedione (phenylbutazone)].
    SCHOETENSACK W; RICHARZ G; BISCHLER P
    Arzneimittelforschung; 1960 Aug; 10():665-76. PubMed ID: 13748426
    [No Abstract]   [Full Text] [Related]  

  • 16. [Synthesis and pharmacological properties of 1-phenyl-2-(4'-hydroxy-3'-carboxymethyl)-phenyl-4-n-butyl-3, 5-dicheto-pyrazolidine and of 1-p-nitrophenol-4-n-butyl-3, 5-dicheto-pyrazolidine].
    BERGESI G; SANTI SONCIN E; STUCCHI F
    Rass Clin Ter; 1961; 60():177-87. PubMed ID: 13867703
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on G-25671, a phenylbutazone analogue (4-phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione).
    BRODIE BB; YU TF; BURNS JJ; CHENKIN T; PATON BC; STEELE JM; GUTMAN AB
    Proc Soc Exp Biol Med; 1954; 86(4):884-7. PubMed ID: 13204385
    [No Abstract]   [Full Text] [Related]  

  • 18. ["Comparative study of several drugs belonging to the group of the 1,2-diphenyl-3,5-diketopyrazolidines. I."].
    PICCININI F; MARAZZI-UBERTI E; LUGARESI C
    Arch Int Pharmacodyn Ther; 1961 Jun; 132():16-28. PubMed ID: 13735416
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calcium derivative of phenylbutazone].
    RATTI G
    Reumatismo; 1957; 9(Suppl 1):95-7. PubMed ID: 13441980
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies of some drugs from the series of 1,2-diphenyl-3,5-pyrazolidinedione. III)].
    PICCININI F; MARAZZI-UBERTI E; TURBA C; COLOMBO-CORTI I
    Arch Int Pharmacodyn Ther; 1963 Feb; 141():480-9. PubMed ID: 13943253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.